 | • レポートコード：MRC2-11QY11157 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は骨・ミネラル代謝障害治療のグローバル市場について調査・分析したレポートです。種類別（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属製バインダー、金属製バインダー、マグネシウム製バインダー、ビタミンD類似体・サプリメント、カルシウム模倣剤、カルシウム・マグネシウムサプリメント）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別骨・ミネラル代謝障害治療の競争状況、市場シェア ・世界の骨・ミネラル代謝障害治療市場：種類別市場規模 2015年-2020年（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属製バインダー、金属製バインダー、マグネシウム製バインダー、ビタミンD類似体・サプリメント、カルシウム模倣剤、カルシウム・マグネシウムサプリメント） ・世界の骨・ミネラル代謝障害治療市場：種類別市場規模予測 2021年-2026年（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属製バインダー、金属製バインダー、マグネシウム製バインダー、ビタミンD類似体・サプリメント、カルシウム模倣剤、カルシウム・マグネシウムサプリメント） ・世界の骨・ミネラル代謝障害治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・世界の骨・ミネラル代謝障害治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・北米の骨・ミネラル代謝障害治療市場分析：米国、カナダ ・ヨーロッパの骨・ミネラル代謝障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの骨・ミネラル代謝障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の骨・ミネラル代謝障害治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの骨・ミネラル代謝障害治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、F. Hoffmann-La Roche、Novartis、Warner Chilcott、Sanofi、AbbVie、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.
Global bone and mineral metabolism disorders treatment market is undergoing market changes due to the higher competition among local and multinational players and this in turn helped to make treatment cost more economical. With the availability of wide variety of products in various forms and strengths in the bone and mineral metabolism disorders treatment market is expected to change the market dynamics over a given period of forecast. By disease type, sub segment such as osteoporosis and rickets in the global bone and mineral metabolism disorders treatment market are expected to grow in positive traction owing to increased prevalence of the diseases among the post-menopausal women and children in the various regions.
Market Analysis and Insights: Global Bone and Mineral Metabolism Disorders Treatment Market
The global Bone and Mineral Metabolism Disorders Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bone and Mineral Metabolism Disorders Treatment Scope and Market Size
Bone and Mineral Metabolism Disorders Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bone and Mineral Metabolism Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen
…
Market segment by Type, the product can be split into
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bone and Mineral Metabolism Disorders Treatment Revenue
1.4 Market by Type
1.4.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bisphosphonates
1.4.3 Estrogens
1.4.4 Phosphate Binders
1.4.5 Non-Calcium, Non-Metal-Based Binder
1.4.6 Metal-Based Binders
1.4.7 Magnesium-Based Binders
1.4.8 Vitamin D Analogs and Supplements
1.4.9 Calcimimetic Agents
1.4.10 Calcium and Magnesium Supplements
1.5 Market by Application
1.5.1 Global Bone and Mineral Metabolism Disorders Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bone and Mineral Metabolism Disorders Treatment Market Perspective (2015-2026)
2.2 Global Bone and Mineral Metabolism Disorders Treatment Growth Trends by Regions
2.2.1 Bone and Mineral Metabolism Disorders Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bone and Mineral Metabolism Disorders Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bone and Mineral Metabolism Disorders Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bone and Mineral Metabolism Disorders Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bone and Mineral Metabolism Disorders Treatment Players by Market Size
3.1.1 Global Top Bone and Mineral Metabolism Disorders Treatment Players by Revenue (2015-2020)
3.1.2 Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bone and Mineral Metabolism Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bone and Mineral Metabolism Disorders Treatment Market Concentration Ratio
3.2.1 Global Bone and Mineral Metabolism Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bone and Mineral Metabolism Disorders Treatment Revenue in 2019
3.3 Bone and Mineral Metabolism Disorders Treatment Key Players Head office and Area Served
3.4 Key Players Bone and Mineral Metabolism Disorders Treatment Product Solution and Service
3.5 Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
5.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
6.2 Bone and Mineral Metabolism Disorders Treatment Key Players in North America (2019-2020)
6.3 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
6.4 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
7.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Europe (2019-2020)
7.3 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
7.4 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
8 China
8.1 China Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
8.2 Bone and Mineral Metabolism Disorders Treatment Key Players in China (2019-2020)
8.3 China Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
8.4 China Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
9.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Japan (2019-2020)
9.3 Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
9.4 Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
10.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
11 India
11.1 India Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
11.2 Bone and Mineral Metabolism Disorders Treatment Key Players in India (2019-2020)
11.3 India Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
11.4 India Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size (2015-2020)
12.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Bone and Mineral Metabolism Disorders Treatment Introduction
13.1.4 Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020))
13.1.5 Merck Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Bone and Mineral Metabolism Disorders Treatment Introduction
13.3.4 Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Warner Chilcott
13.4.1 Warner Chilcott Company Details
13.4.2 Warner Chilcott Business Overview
13.4.3 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Introduction
13.4.4 Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.4.5 Warner Chilcott Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Bone and Mineral Metabolism Disorders Treatment Introduction
13.5.4 Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview
13.6.3 AbbVie Bone and Mineral Metabolism Disorders Treatment Introduction
13.6.4 AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.6.5 AbbVie Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview
13.7.3 Amgen Bone and Mineral Metabolism Disorders Treatment Introduction
13.7.4 Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020)
13.7.5 Amgen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bone and Mineral Metabolism Disorders Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bone and Mineral Metabolism Disorders Treatment Revenue
Table 3. Ranking of Global Top Bone and Mineral Metabolism Disorders Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Estrogens
Table 7. Key Players of Phosphate Binders
Table 8. Key Players of Non-Calcium, Non-Metal-Based Binder
Table 9. Key Players of Metal-Based Binders
Table 10. Key Players of Magnesium-Based Binders
Table 11. Key Players of Vitamin D Analogs and Supplements
Table 12. Key Players of Calcimimetic Agents
Table 13. Key Players of Calcium and Magnesium Supplements
Table 14. Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2015-2020)
Table 18. Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Bone and Mineral Metabolism Disorders Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Bone and Mineral Metabolism Disorders Treatment Players
Table 25. Global Bone and Mineral Metabolism Disorders Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Players (2015-2020)
Table 27. Global Top Bone and Mineral Metabolism Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone and Mineral Metabolism Disorders Treatment as of 2019)
Table 28. Global Bone and Mineral Metabolism Disorders Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Bone and Mineral Metabolism Disorders Treatment Product Solution and Service
Table 31. Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Type (2015-2020)
Table 35. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Application (2015-2020)
Table 37. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 41. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 43. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 47. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 49. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 53. China Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 55. China Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 59. Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 61. Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 65. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 71. India Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 73. India Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2019-2020)
Table 77. Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2015-2020)
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Product
Table 89. F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Warner Chilcott Company Details
Table 97. Warner Chilcott Business Overview
Table 98. Warner Chilcott Product
Table 99. Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 100. Warner Chilcott Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Product
Table 114. Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Type: 2020 VS 2026
Figure 2. Bisphosphonates Features
Figure 3. Estrogens Features
Figure 4. Phosphate Binders Features
Figure 5. Non-Calcium, Non-Metal-Based Binder Features
Figure 6. Metal-Based Binders Features
Figure 7. Magnesium-Based Binders Features
Figure 8. Vitamin D Analogs and Supplements Features
Figure 9. Calcimimetic Agents Features
Figure 10. Calcium and Magnesium Supplements Features
Figure 11. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Application: 2020 VS 2026
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Online Pharmacies Case Studies
Figure 15. Drug Stores Case Studies
Figure 16. Bone and Mineral Metabolism Disorders Treatment Report Years Considered
Figure 17. Global Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions: 2020 VS 2026
Figure 19. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Players in 2019
Figure 22. Global Top Bone and Mineral Metabolism Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone and Mineral Metabolism Disorders Treatment as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Bone and Mineral Metabolism Disorders Treatment Revenue in 2019
Figure 24. North America Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
アミノ酸代謝異常治療の世界市場（～2026年） Market Analysis and Insights: Global Amino Acid Metabolism Disorders Treatment Market The global Amino Acid Metabolism Disorders Treatment market size is projected to reach US$ 578.9 million by 2026, from US$ 547 million in 2020, at a CAGR of 5.3%% during 2021-2026. Global Amino Acid Metabolism Diso…- 骨・ミネラル診断検査の世界市場（～2026年） Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsib…
- 骨・ミネラル検査の世界市場（～2026年） Bone & mineral tests are used for diagnosis and evaluation of changes in response to bone disorder therapy. Market Analysis and Insights: Global Bone & Mineral Testing Market The global Bone & Mineral Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- ブレストバインダーの世界市場（～2026年） Breast Binders are made of soft cotton. They are machine washable, durable compression garments that aid in reducing bruising and swelling following invasive breast procedures. These Breast Binders for women are Latex free, easy to put on, and attractive to wear. The E-a-B Breast Binders are capable…